VNRX VolitionRx Limited
Stock Price & Overview

$0.47-0.027 (-5.46%)4:00 PM 05/13/25
NYSE | $USD | Post-Market: $0.49 +0.02 (+5.28%) 6:22 PM

VNRX Stock Price

EPS
PE
Div Rate
Yield
Short Interest
Market Cap
Volume
Prev. Close

Quant Ranking

Latest Headlines

Ratings Summary

People Also Follow

Similar to VNRX

ETFs Holding VNRX

VNRX Company Profile

VolitionRx Limited logo
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and diseases associated with NETosis such as sepsis in the United States and internationally. It offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis such as sepsis; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.
Employees
85
Founded
-
Address
  • 1489 West Warm Springs Road
  • Suite 110
  • Henderson, NV, 89014
  • United States
Phone Number
646 650 1351

VNRX Revenue

VNRX Earnings Per Share

Earnings Estimates

Earnings Revisions

Valuation

Growth

Profitability

Momentum

Capital Structure

Dividends

VNRX does not currently pay a dividend.

VNRX Ownership

VNRX Peers

Risk

Technicals

VNRX Transcripts

Investor Presentations

VNRX SEC Filings

VNRX Income Statement

VNRX Balance Sheet

VNRX Cash Flow Statement

VNRX Long Term Solvency

Discover More

You may be interested in:

VolitionRx Limited (VNRX) Frequently Asked Questions